Geneos Therapeutics

Geneos Therapeutics has developed a personalized immunotherapy based on neoantigens for cancer treatment. The company's technology aims to identify relevant neoantigen targets from individual patients' tumors, thereby developing new cancer treatments and providing tumor-targeted immunotherapy to cure their diseases.